...
首页> 外文期刊>Gene Therapy and Molecular Biology >Genetically modified stem cells for cellular therapy
【24h】

Genetically modified stem cells for cellular therapy

机译:转基因干细胞用于细胞治疗

获取原文
           

摘要

Stem cells carry the promise to cure a broad range of diseases and injuries, from diabetes, to neurological diseases and injuries. Over the past decade, significant progresses have been made in stem cell research; the derivation of embryonic stem cells (ESCs) from human tissues, the development of somatic cell nuclear transfer (SCNT) technology, and the confirmation that neurogenesis occurs in the adult mammalian brain, including in human. Despite these advances, there may be decades before stem cell research translates into therapy. Beside the scientific and technical challenges, there are ethical and political constraints and debates over stem cell research, particularly on ESCs and SCNT. In this manuscript, I will discuss how gene therapy is applied to stem cell research, in an attempt to unlock some of the technical, ethical and political hurdles associated with stem cell research.
机译:干细胞有望治愈多种疾病和损伤,从糖尿病到神经系统疾病和损伤。在过去的十年中,干细胞研究取得了重大进展。从人体组织衍生胚胎干细胞(ESC),发展体细胞核移植(SCNT)技术,并确认神经发生发生在成年哺乳动物的大脑中,包括人类。尽管取得了这些进步,但干细胞研究可能需要数十年才能转化为治疗方法。除了科学和技术挑战之外,在干细胞研究方面,特别是在ESC和SCNT方面,还存在伦理和政治限制以及辩论。在本手稿中,我将讨论如何将基因疗法应用于干细胞研究,以期解决与干细胞研究相关的一些技术,伦理和政治障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号